- Trabectedin, sold
under the
brand name
Yondelis, is an
antitumor chemotherapy medication for the
treatment of
advanced soft-tissue
sarcoma and ovarian...
-
based on
toxins and
other molecules of
animal origin. The
cancer drug
Yondelis was
isolated from the
tunicate Ecteinascidia turbinata. One of
dozens of...
-
Eprex Erleada Imbruvica Procrit Rybrevant Talvey Tecvayli Valchlor Velcade Yondelis Zytiga Cardiovascular, metabolism, and
retina therapies Xarelto Invokana...
-
Talvey Tecvayli Terazol Topamax Tremfya Ultracet Ultram Vermox Xarelto Yondelis Zytiga Opsumit Tracleer Zavesca Uptravi Veletri Vintivis Vermax Medtech...
- more expensive. For example, ET-743 (INN name trabectedin,
brand name
Yondelis) can be
isolated from the
tunicate Ecteinascidia turbinata with a yield...
-
clinical trials and is
already in use in
Europe under the
trade name "
Yondelis" for
treatment of
certain soft
tissue sarcomas and
recurrent ovarian cancer...
- Squibb)
Yesafili Yescarta Yocon (Teva Pharmaceuticals)
yohimbine (INN)
Yondelis Yonsa Yorvipath Yselty Yttriga yttrium (Y 90)
clivatuzumab tetraxetan (USAN)...
-
Hornicek FJ (2009). "ZNF93
increases resistance to ET-743 (Trabectedin;
Yondelis) and PM00104 (Zalypsis) in
human cancer cell lines". PLOS ONE. 4 (9): e6967...
-
Tunisie par BRLi (in French), vol. Mar 21, 2012,
retrieved 2022-11-27 "
Yondelis Trabectedin is a
synthetic compound derived from the
colonial sea squirt...
-
PharmaMar (Spain)
enter into a
license agreement on
anticancer agent,
Yondelis Taiho History Museum completed at the
Tokushima Plant Marketing approval...
